When manufacturers profit from misleading "GLP-1 friendly" labeling while marketing nutritionally inadequate products, The Lyon Firm has the experience and resources to investigate potential violations, develop litigation strategies, and pursue remedies benefiting affected consumers nationwide
Nat Rev Cancer 2006
However, excessive dosing can still lead to complications
However, these mostly depend on a stabilized supply-chain of GLP-1 production, further development of the medication into a potential pill format, expanded health insurance coverage (including Medicare), FDA approval for obesity treatment specifically, and decreasing costs of GLP-1s
Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders
Tirzepatide (Mounjaro, Zepbound) is a related but distinct medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor co-agonist